EP 250: Redefining rare disease realities with Sharon Terry of the Genetic Alliance [Re-run]

Value of the Information & Strength of the Argument

The episode provides valuable insights into the rare disease ecosystem from a patient advocate’s perspective. Sharon Terry’s arguments are well-founded, drawing on decades of hands-on experience in establishing biobanks, leading advocacy efforts, and implementing global genetic testing programs. She effectively argues for a paradigm shift in how rare diseases are approached, advocating for public health subsidies and international collaboration. The discussion is coherent and persuasive, though it relies on anecdotal evidence and personal experience rather than formal research data.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is moderate, as the content is primarily based on the guest’s extensive practical experience and opinions. While she references specific programs (e.g., iHope, GINA) and collaborations (e.g., IRDiRC), no formal sources are cited. The title accurately reflects the content, focusing on redefining rare disease realities through advocacy and systemic change. The episode does not include a promotional segment.

The title accurately reflects the content, focusing on redefining rare disease realities through the lens of Sharon Terry's work and advocacy.

8/10

The episode features a highly experienced patient advocate and leader in rare disease research, providing credible firsthand insights. The discussion is based on extensive practical experience and references to established programs and policies. However, it is an interview and opinion-based, lacking formal citations or peer-reviewed evidence.

• 00:00Intro to The Genetics Podcast
• 01:00Welcome to Sharon and a discussion of the personal experience with rare disease that started her journey
• 03:57Reasons Sharon decided to establish the first layperson-led biobank
• 05:46Challenges with setting up the biobank infrastructure
• 07:15Balancing financial factors in a non-profit organization
• 09:49Recent patterns and future insight into rare disease drug discovery framework and regulation
• 16:06Barriers to widespread collaboration and cooperation in the rare disease research, and why it should be approached from a public health perspective
• 18:51Background and experiences from the iHope Genetic Health program in low- to middle-income countries
• 25:47Sharon’s perspective on challenges with the Genetic Information Non-discrimination Act
• 30:01Sharon’s lessons learned in her patient advocacy and policy work, and her hopes for future legislation
• 34:25Sharon’s hopes for improved access to genetic testing and treatment for children in underserved communities
• 35:58How Sharon learned about rare diseases and genetics as a “homeschooling mom without a degree”
• 39:26Insights into how elements of spirituality can support advocacy work
• 42:21Closing remarks